Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on LI 3. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103980249A details high purity alogliptin benzoate refining. Enhances supply chain reliability and reduces manufacturing complexity for global pharmaceutical procurement teams.
Novel double dearomatization method for spiro-indolizidines. High yield up to 95%. Cost-effective route for API intermediates without precious metals.
Patent CN113801903B reveals enzymatic route for sitagliptin intermediate offering high purity and supply chain stability for global API manufacturers.
Novel amorphous nickel alloy catalysis for m-(β-hydroxyethylsulfone) aniline production offers high yield, reduced pollution, and extended catalyst life for dye manufacturers.
Patent CN103012082B offers high-yield synthesis for supramolecular materials, ensuring supply chain stability and cost efficiency.
Patent CN103555608B reveals high-efficiency biocatalytic route for chiral intermediate. Enables cost reduction and supply chain reliability for pharma.
Novel Rh-catalyzed regioselective synthesis of pyrazolidone-benzo 1,3-oxazepines. High atom economy, mild conditions, scalable route for API intermediates.
Patent CN1213991C reveals a copper-catalyzed route for high-purity sertraline intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN104371008B reveals high-purity terlipressin synthesis via fragment condensation, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel synthesis of 4-ethyl-7,8-dihydro-IH-pyrano[3,4-f]indolizine-3,6,10(4H)-trione offering cost reduction and safer scale-up for API manufacturing.
Patent CN106905226A reveals a cost-effective, three-step synthesis for Alectinib intermediates. Discover scalable, high-yield manufacturing solutions for global supply chains.
Novel patent CN106892860B offers cost-effective Alectinib intermediate synthesis. Enhances supply chain reliability and reduces manufacturing complexity for global pharmaceutical partners.
Patent CN114539251A reveals a green, one-step silver-catalyzed route for pyrido[2,3-d]pyrimidine derivatives, offering significant cost reduction and supply chain stability for API manufacturing.
Patent CN101786983A reveals a mild one-pot synthesis for 2-amino-1,2-dihydroisoquinolines using AgOTF and NHC catalysts, offering high purity and scalable manufacturing for pharmaceutical intermediates.
Patent CN117362311A reveals novel forskolin analogue synthesis. Enables cost reduction in pharmaceutical intermediate manufacturing with scalable routes.
Novel forskolin analogue synthesis via Pd-catalyzed coupling. Offers high purity pharmaceutical intermediates for oncology research and drug discovery.
Novel synthesis patent CN103864618A offers high yield and mild conditions for pharmaceutical intermediates, ensuring supply chain stability and cost efficiency.
Novel Pd-NHC catalyzed process offers high purity pharmaceutical intermediates with reduced cost and scalable supply chain reliability for global partners.
Patent CN103044421B reveals efficient palladium-catalyzed synthesis. Offers supply chain stability and cost reduction in pharmaceutical intermediate manufacturing for global buyers.
Novel solid-phase synthesis of goserelin using CDI activation improves yield and purity. Cost-effective manufacturing for pharmaceutical intermediates.